Introduction {#Sec1}
============

Zebrafish (*Danio rerio*) is a small teleost that can be maintained in small aquaria. The main advantage of working with zebrafish is that it is an animal with all characteristics of vertebrates and an organism with external fertilization. These features, coupled with the fact that its embryo is semitransparent during early life stages, open the possibility to follow early development and organogenesis directly in vivo, without the need for invasive procedures. Moreover, zebrafish are particularly fertile and a healthy adult female can lay hundreds of eggs in a month. For these reasons, zebrafish is the first vertebrate model in which large-scale random mutagenesis could be undertaken (Driever et al. [@CR15]; Haffter et al. [@CR19]). The zebrafish genome has recently been sequenced and assembled, but its annotation is still ongoing. Moreover, until few years ago, genetic manipulation technology lacked a direct tool for targeting the zebrafish genome, but recently techniques have evolved through the use of TILLING (McCallum et al. [@CR35]; Wienholds et al. [@CR62]; Sood et al. [@CR52]), zinc-finger nucleases (Meng et al. [@CR36]; Doyon et al. [@CR14]) and now TALEN mutagenesis, allowing conditional gene targeting (Sander et al. [@CR47]; Huang et al. [@CR22]). Being a vertebrate, zebrafish has immediately gained acceptance as a model organism in which human diseases can be phenocopied. In fact, many human diseases can be modeled in zebrafish and several laboratories all over the world are now generating fish with diseases that resemble, either at the molecular, cellular, etiological or histopathological level, human diseases. Several zebrafish models of cancer, metabolic, developmental, aging, degenerative, sensory organ and infectious diseases have been generated (reviewed in Lieschke and Currie [@CR32]; Mione and Trede [@CR37]; Kanther and Rawls [@CR23]; Liu and Leach [@CR33]; Goldsmith and Jobin [@CR16]). This scenario makes zebrafish an ideal candidate for screening disease modifiers, genes, drugs or behavioral and environmental mechanisms able to modify specific phenotypes.

The knowledge of molecular and biochemical processes regulating cell proliferation, differentiation, survival, and death is the basis for understanding animal development, tissue homeostasis and tumor growth. Many embryonic and postnatal signaling pathways, which are often disrupted in cancer and diseases, appear to play a central role. Particularly important in regulating cell proliferation, stem cell maintenance and differentiation are bone morphogenetic proteins (BMPs), notch, wingless-related integration site (Wnt), sonic Hedgehog (Shh), fibroblast growth factor (FGF), signal transducer and activator of transcription (STAT), activator protein 1 (AP1) and cAMP-response element-binding protein (CREB) signaling (reviewed in Perrimon et al. [@CR44]; Aaronson and Horvath [@CR1]; Hess et al. [@CR21]; Stork and Schmitt [@CR55]). In fact, research at the tissue and cellular level is deeply oriented toward dissection of these pathways, as well as understanding their cross-talk and epistatic relations (Davidson [@CR9]; Corson and Siggia [@CR7]). As these pathways are relays of signal transduction, culminating with the activation of arrays of genes by specific set of transcription factors (TFs), it has been important in the last 30 years to understand the precise sequences and logic of gene activation. Typically, the analysis of genetic cascades culminates in dissecting *cis*-elements in the promoters of relevant target genes and the subsequent isolation of the TFs binding to these *cis*-elements. This approach leads to the isolation of relevant TFs in genetic cascades and the exact knowledge of the activator sequences in the promoters and enhancers of target genes (reviewed by Khalil et al. [@CR27]). The direct and final proof that a specific TF (and thus the upstream genetic cascade) is involved in gene activation through a specific nucleotide sequence (*cis*-element) comes from the strong and tunable activation of synthetic constructs bearing multimerized copies of the *cis*-element bound to a minimal promoter of a reporter gene. In this way, a huge amount of data have been produced by transfection of a specific cell line together with the reporter and components of the signal transduction cascade. However, this approach might lack in vivo relevance, as co-transfection of a reporter plasmid together with its transduction and TFs leads, by default, to reporter signal. For this reason, a number of transgenic animal reporter lines have been developed, from mice to *Drosophila* and, recently, zebrafish. In this review, we will focus on the advantage of using zebrafish in this approach, to convince the reader that embryo and larval transparency, genetic and chemical manipulation, screening properties and transgenic manipulability, make zebrafish an ideal tool for analytical screenings and analysis of pathway reporters.

Development of signaling pathway reporters (SPRs) {#Sec2}
=================================================

The generation of reliable transgenic fish expressing in vivo reporter proteins under the control of signaling pathway responsive elements depends on four major critical issues: (a) choice of a suitable transgenesis method; (b) design and optimization of multimerized signaling responsive elements; (c) the use of a non-tissue specific and strong minimal promoter and (d) selection of an appropriate reporter protein (e.g. GFP, DsRed, mCherry, Kaede, Caerulean, YFP).

(a) Transgenesis {#Sec3}
----------------

An ideal targeting vector should have a limited size and a high efficiency of germline transmission. Since the first successful attempt to introduce foreign DNA into the zebrafish germline (Stuart et al. [@CR56]), considerable advances have been made in the field of gene transfer in fish. The initial method of transgenesis in zebrafish entailed the microinjection of linearized plasmids into fertilized eggs. However, this approach suffered from many drawbacks, including low rate of germline transmission and mosaic expression of the introduced transgene. Despite its limited yield and other minor issues, the first Wnt reporter line was established in the laboratory of Randall Moon in 2002 using this method (Dorsky et al. [@CR12]).

An alternative transgenesis approach utilizes the I-SceI meganuclease, which was successfully introduced at first in Medaka (*Oryzias latipes*) and showed higher rates of germline transmission (Thermes et al. [@CR57]). This method relies on the generation of a targeting sequence flanked by two recognition sites for the I-SceI enzyme, an intron-encoded homing endonuclease isolated from the yeast *Saccharomyces cerevisiae*. Co-injection of the vector with the I-SceI meganuclease significantly increases the rate of germline integration, thus improving the frequency of positive founder fish in F0. In zebrafish, the I-SceI mediated transgenesis protocol was shown to increase the transgenesis efficiency up to 45 % (Soroldoni et al. [@CR53]). The combined use of a dual specificity phosphatase 6 (DUSP6) promoter-containing vector and the I-SceI meganuclease allowed the generation of the first transgenic reporter line specific for the FGF signaling pathway (Molina et al. [@CR39]).

The development of the Tol2 technology has revolutionized transgenesis methods for aquatic vertebrates, such as zebrafish (Kawakami et al. [@CR26]; Kawakami [@CR24]; reviewed in Kawakami [@CR25]). This method relies on the microinjection into fertilized eggs of a transposon-donor plasmid named Tol2, and a synthetic mRNA encoding the transposase, to catalyze DNA excision and recombination within the targeted genome. When considering the high integration frequency of the donor plasmid into the host genome during early stages of development, germline precursor cells carry at least one copy of the integrated plasmid and transmit it to the offspring with transgenesis rates that reach up to 70 % of the microinjected fish.

The Tol2 transgenesis method has been settled in most zebrafish laboratories worldwide and, in the past few years, many cell signaling reporter fish have been established through the application of this method (Schwend et al. [@CR49]; Laux et al. [@CR30]; Collery and Link [@CR6]; Moro et al. [@CR41]). Figure [1](#Fig1){ref-type="fig"} summarizes the main steps to generate a zebrafish reporter line by the Tol2 strategy.Fig. 1Generation of SPR zebrafish lines (Tol2 method). Pathway-specific responsive/regulatory elements (REs) can be obtained from literature data or predicted by in silico analysis (e.g. through UCSC Genome Browser) of conserved regions close to known target genes. To enhance the responsiveness of the planned reporter, REs can be multimerized, thus potentially recruiting more signal-dependent transcription factors (TF). Multimerized REs are cloned upstream of a Reporter gene coding for a fluorescent protein, provided with minimal promoter (MP) and polyA signal site (polyA), exploiting, for instance, the Gateway-based recombination cloning strategy. For Tol2 transgenesis, the complete transgene is cloned into a final destination vector with Tol2 integration sites. The construct is then co-injected into zebrafish zygotes along with the Tol2 transposase messenger RNA. The corresponding translated enzyme catalyzes the integration of the transgene into the zebrafish genome. F0 embryos are screened for their fluorescence (which may vary among individuals) and raised to adulthood (ca. 3 months). Putative founders are outcrossed with wild type fish and their F1 progeny screened for stable transgene integration and inheritance pattern

(b) Minimal regulatory elements {#Sec4}
-------------------------------

In most transgenic reporters, the responsiveness to a particular signaling pathway is achieved through the activation by TFs of regulatory elements located upstream to the coding sequences of a reporter protein (i.e. GFP). Pathway specificity and sequence information on these responsive elements can often be obtained through literature search, or identified by in silico analysis, taking advantage of ad hoc bioinformatics platforms. These sequence alignment tools are classically intended to compare promoter regions of co-expressed target genes, and are designed to detect evolutionarily conserved elements shared among different species (e.g. by phylogenetic footprinting) (Loots [@CR34]). To enhance the reporter responsiveness, these regulatory DNA elements are synthesized in tandem repeats. This is, for instance, the case of the first zebrafish Wnt reporter line, which was created through the juxtaposition of four DNA regulatory elements specifically binding the TCF/Lef complex in Wnt responsive cells (Dorsky et al. [@CR12]). The number of repeats and the extent of the binding consensus sequences of each repeat significantly affect the sensitivity of the reporter fish in terms of both expression levels and tissue specificity of reporter protein expression. In agreement with this hypothesis, a direct comparison between two Wnt reporter lines, the TOPdGFP (Dorsky et al. [@CR12]) and the more recent TCFsiam Tg(7xTCFX.lasiam:GFP)ia4 (Moro et al. [@CR41]), has been recently addressed. In the TOPdGFP transgenic line, four TCF/Lef responsive elements are located upstream of a cFos minimal promoter and the reporter protein coding sequence (d2GFP, destabilized GFP), while in the TCFsiam the reporter protein expression is driven by a multimerized array of seven TCF/Lef elements and a *Xenopus leavis* siamois gene minimal promoter. The TCFsiam line exhibits a higher mRNA expression level and a wider range of reporter protein-expressing domains in living embryos, which persists until late adulthood, supporting the idea that a higher number of responsive elements enhances the responsiveness of the reporter system to the binding TFs. However, while one could argue that differences in the minimal promoter sequence of the two Wnt lines, cFos and siamois, respectively, could account for the discrepancy in reporter activities, other explanations may derive from direct comparison of lines harboring the same minimal promoter, but a different number of responsive elements, as exemplified by the Notch reporter. The published Notch transgenic line, Tg(T2KTp1bglob:hmgb1-mCherry)jh11, is made of six copies of the promoter from the Epstein-Barr virus terminal protein (TP1) gene, each containing two Rbp-Jk binding sites, for a total of 12 Notch responsive elements (NREs), upstream to the rabbit beta-globin minimal promoter and the mCherry coding sequence (Parsons et al. [@CR43]). We have recently generated two Notch reporter fish lines, one with 12 NREs and one with only 6 NREs upstream of the same minimal promoter and reporter protein coding sequence eGFP (unpublished data). When compared with the 12xNRE Notch reporter line, the 6xNRE transgenic fish show an identical domain of expression, but a less intense fluorescent signal in the Notch responsive cells (Fig. [2](#Fig2){ref-type="fig"}, compare a with a′). This observation suggests that cooperativity between responsive sequences affects the levels of reporter protein expression positively. At this point, it is important to stress that a higher responsiveness (potentially leading to signal saturation) does not translate to a better sensitivity of a specific reporter line in a particular experimental context. Indeed, the simultaneous use of different transgenic reporter lines with a different responsiveness for a given signaling pathway may be a better tool to address a specific biological question. To support this concept, very elegant work by the group of Richard Dorsky on Wnt pathway-dependent regulation of hypothalamic progenitors using two distinct reporter lines was recently published (Wang et al. [@CR60]). This study took advantage of both stable and destabilized Wnt-responsive lines for two different purposes: the destabilized *TOP:GFP* reporter was used to rapidly assess conditionally induced Wnt inhibition in the hypothalamic region, while the long half life of GFP in the *TCFSiam:GFP* reporter was exploited to evaluate which hypothalamic lineages were derived from Wnt-responsive cells. A further example is shown in Fig. [2](#Fig2){ref-type="fig"}, where drug response of our 6xNRE reporter line is compared with that of 12xNRE transgenic fish. Both lines were treated with the Notch inhibitor DAPT and their fluorescence in vivo monitored at different time points (Fig. [2](#Fig2){ref-type="fig"}, compare a--c with a′--c′). After a 24-h treatment, the eGFP fluorescence is completely abolished in the 6xNRE line, while residual reporter protein is still present in the 12xNRE line, indicating the 6xNRE line as a faster biosensor to screen in vivo for Notch perturbing molecules. It is noteworthy that, compared to the fluorescent reporter, in situ hybridization analysis of the corresponding mRNAs shows faster dynamics (Fig. [2](#Fig2){ref-type="fig"}, compare d--f with d′--f′).Fig. 2Number of responsive elements and reporter line sensitivity. Zebrafish embryos from two Notch-responsive lines, differing in the number of Notch-responsive elements (6x and 12xNRE), were treated with the Notch-inhibitor DAPT (100 µM) from 2 to 4 days post-fertilization. Controls were treated with a corresponding amount of carrier solution DMSO. **a**--**c**, **a**′--**c**′ In vivo analysis after 12 and 24 h of incubation shows faster decrease in EGFP reporter fluorescence in the 6xNRE line (**a**--**c**), as compared to 12xNRE fish (**a**′--**c**′). Complete suppression of EGFP fluorescence in 12xNRE embryos requires an extra day of incubation (not shown). **d**--**f**, **d**′--**f**′ Postmortem analysis by whole-mount in situ hybridization (WISH), with DIG-riboprobes specific for *egfp* mRNA, shows a rapid decrease of reporter messenger in both transgenic lines. WISH staining used far-red emitting fast blue, enhanced by alkaline-phosphatase-conjugated anti-DIG antibodies. All images were acquired with a Leica SP5 confocal microscope and processed by Volocity 6.0 software. *Allpanels* are dorsal views of the head region, anterior to the left. **a**, **b**, **a**′, **b**′, **d**, **e**, **d**′, **e′** 60 h post-fertilization (hpf) stage; **c**, **c**′, **f**, **f**′ 72 hpf stage

(c) Minimal promoter for SPRs {#Sec5}
-----------------------------

Another key element that needs to be considered when designing SPR fish is the minimal promoter, which lies downstream of the signaling responsive elements. As previously pointed out (Barolo [@CR4]), the use of minimal promoters taken from genes that are transcriptional targets of a specific signaling pathway is of great relevance when setting up a fish reporter for the chosen pathway. Both the TOPdGFP (Dorsky et al. [@CR12]) and the TCFsiam lines (Moro et al. [@CR41]), in which the minimal promoters used are cFos and siamois, respectively, show Wnt-dependent activation of the reporter transgene in several tissue contexts. On the other hand, however, very recent work by Shimizu et al. ([@CR51]) argued that in several Wnt reporter lines, including TOPdGFP and TCFSiam, the minimal promoters were derived from the promoters of natural genes, containing not only TATA, but also sequences derived from each gene promoter, which may be affected by non-specific signals. The authors suggested that the use of an artificial minimal promoter, such as the pGL4 vector-derived promoter called miniP, might increase the responsiveness and sensitivity of the reporter protein detection, reducing potentially unspecific signal. It should be emphasized that the choice of a particular minimal promoter does not follow a specific rule; therefore, when designing a SPR vector to be used in zebrafish, different minimal promoters might be tested in advance to select the one with maximal signal to noise ratio. Moreover, it should be clear that every newly designed SPR fish might suffer from limitations in terms of expression domains, as previously suggested (Barolo [@CR4]).

(d) The reporter protein {#Sec6}
------------------------

The selection of a particular reporter protein is highly dependent on the type of research that is carried out. The choice of the best fluorophore should take into consideration a series of critical issues (reviewed in Miyawaki [@CR38]; Shaner et al. [@CR50]; Müller-Taubenberger and Anderson [@CR42]), including type of color (e.g. based on the available optics or double-transgenic design), brightness, toxicity, tissue penetration, subcellular localization, availability of modified versions (e.g. convertible, toxic, stable or destabilized reporters) and so on. When addressing a biological question, dealing with rapid tissue or cell dynamics, a destabilized reporter protein, such as d2EGFP or VENUS-Pest are recommended. The application of such reporter systems has proven valuable, for instance, in detecting cell signaling changes during early stages of differentiation (Collery and Link [@CR6]; Wang et al. [@CR60]) or testing small chemical effects in short time ranges (Molina et al. [@CR40]). However, the use of destabilized proteins often suffers from many drawbacks, including the low amount of detectable accumulating protein during a biological event. Therefore, especially for experimental tests involving analysis of cell signaling dynamics or cell lineage tracking over a long time range, the use of long half-life fluorescent proteins is suggested. We recently addressed the use of the Wnt reporter line, TCFsiam, to follow the cellular fates of neural crest-derived cells (NCdC) in the brain and trunk mesoderm. Using the stable GFP-expressing coding sequence, we were able to track the cellular division of NCdC in the CNS blood vessels for 9 h, a period far longer than the half life of the d2EGFP turnover (Moro et al. [@CR41]). The use of a destabilized protein probably would not have allowed the detection of such cell division, as a consequence of low d2EGFP accumulation, given that its half life is 2 h.

Once all major variables (choice of targeting vector, number of responsive sequences, minimal promoter and reporter protein) have been addressed, the required components of the responsive transgene are routinely assembled into a final destination construct, for instance taking advantage of a Gateway-based Tol2 strategy (Kwan et al. [@CR29]), and then microinjected into one cell-stage zebrafish embryos. It is generally assumed that Tol2 transgenesis leads to single gene integration into the host genome (Kawakami [@CR25]). However, in practical experience, it is commonly observed that the generation of a new transgenic animal may be affected by multiple integration events occurring in the germline of microinjected fish. Considering that during multiple integration events, a transgene may be conditionally and spatially influenced at the transcriptional level by the genomic neighborhood (the so-called "positional effect"), some of the signaling reporter lines so far generated may display different patterns of expression in distinct isolated founders. This effect could hamper downstream applications and potentially generate misleading biological interpretations. It is of great relevance in such cases to carry out rigorous analysis and validation protocols to establish the accuracy of newly generated SPR lines.

Validation of SPR lines {#Sec7}
=======================

How can we confirm that a given zebrafish transgenic line is a *bona fide* reporter for a specific signaling pathway? Here, we propose guidelines meant to provide consistency to a newly generated SPR line.

There are at least four major approaches to validate a SPR fish line: (a) comparison of multiple reporter lines, (b) literature review, (c) genetic analysis, and (d) pharmacological screening.

A first indication on reporter specificity can be obtained from simultaneous production and reciprocal comparison of multiple lines. The analysis of the progeny from several founder fish allows evaluation of whether a given transgene is consistently expressed in the same set of anatomical districts at equivalent time points. Differences in pattern and intensity among siblings are mostly due to position variegation effects or multiple insertions in the same founder (different alleles in the same carrier). On the other hand, possible discrepancies among progeny from different monoallelic founder fish are mainly ascribed to random positional effects due to the genomic context in which the single transgene integrated (Molina et al. [@CR39]; Schwend et al. [@CR49]; Moro et al. [@CR41]). In our experience, these effects need to be attenuated by diluting the number of transgenic copies through subsequent generations, while keeping selected individuals with brightest and most shared positive signals, until the outcross will give a Mendelian proportion (50 % transgenic embryos) in progeny where sibs share similar expression levels. Generation and intercross of lines driving differently labeled reporters may further simplify these comparisons; exploiting dual color co-localization analysis of reporter expression in lines responsive to the same signaling pathway is a direct proof of identical or very similar pattern of expression and lack of a significant position effect.

Another basal set of evaluation criteria concerns the analysis of reporter expression compared to data available in current literature. The unequivocal identification of positive areas may require accurate morphological analysis, intercross of the reporter line with tissue-specific transgenic lines, or application of immunohistochemistry techniques. For instance, two-color fluorescent in situ hybridization, using reporter-specific probes (e.g. against GFP) in combination with other markers, may be particularly helpful in the validation process. Detected areas of reporter expression can thus be compared with known profiles of pathway-related target genes, or with anatomical districts whose development and function were previously linked to the activity of the pathway under investigation.

Finally, the last fundamental step in the validation of a biosensor line implies a series of functional studies, aimed to perturb a given pathway to verify whether the transgene is sufficiently sensitive in reporting signaling variations. These studies may apply genetic strategies, including over-expression of messengers encoding for pathway members, use of zebrafish mutants with defective signaling, or injection of antisense morpholino oligos. In some cases, these methodologies may be hindered by gene redundancy, non-specificity, hypomorphisms or other limitations, but, where effective, they appear convincing validations. In parallel, pharmacological approaches may be also adopted, such as treatments with agonistic/antagonistic drugs, aimed to perturb a given pathway at different levels of the signaling cascade. In the former type of validation methodology, based on the genetic approaches, the SPR line is generally tested with targeted antisense morpholino oligos against the specific molecules that directly drive or positively modulate the expression of the reporter transgene. As an example, the Tg(BmpRE:EGFP)pt510, which faithfully responds to BMP signaling activity, was successfully tested with SMAD5 and SMAD1 morpholinos (Laux et al. [@CR30]). Knockdown of SMAD1 significantly dampens EGFP expression in many domains of the reporter line, confirming that the reporter expression is strictly regulated by nuclear TFs or cytoplasmic proteins that bind the responsive elements (in that case, ID1 protein responsive elements) in the nucleus.

However, given the transient activity and limited penetrance of morpholinos, the use of genetic mutants to test a SPR line is often favorable. In this case, the reporter line is first out-crossed with the genetic mutant, and then the offspring are intercrossed to generate homozygous mutants in the reporter background. If in the mutant the altered gene is a positive modulator of the signaling pathway displayed by the SPR, the homozygous fish mutants may show a complete abrogation of reporter expression in most tissue domains. This effect was partially shown in the Tg(Gli-d:mCherry) line, which display mCherry expression in Shh responsive domains (Schwend et al. [@CR49]). The construct used to generate the line was tested in *detour*/*gli1* (dtrts69), *you*-*too*/*gli2* (yotty119), and *slow*-*muscle*-*omitted*/*smu* (smub641) mutants, and the lack of reporter expression allowed the authors to claim that their reporter line was a *bona fide* Shh reporter.

Because many genetic mutants are not viable beyond few days post-fertilization, the use of conditional systems, such as heat shock inducible lines, may be an ideal alternative approach to validate a SPR. For instance, the BMP signaling reporter Tg(BRE-AAVmlp:d2GFP)mw30 line was tested by performing intercrosses with Tg(hsp70 l:bmp2b)fr13 or with Tg(hsp70 l:nog3)fr14 line, which globally over-expresses zebrafish Bmp2b or the BMP inhibitor Noggin in response to heat-shock (Chocron et al. 2007), respectively. After heat shock, the double Tg(BRE-AAVmlp:d2GFP)mw30;Tg(hsp70 l:bmp2b)fr13 offspring displayed greatly increased expression of the d2GFP reporter, while in contrast Tg(BRE-AAVmlp:d2GFP)mw30;Tg(hsp70 l:nog3)fr14 double transgenic embryos showed reduced d2GFP levels. Similarly, we have recently tested the Tg(hsp70 l:dkk1-GFP) line (Stoick-Cooper et al. [@CR54]) in the Wnt reporter background, showing that heat-shock induced expression of the Wnt antagonist Dkk1 is able to reduce the amount of Wnt-responsive reporter protein (Moro et al. [@CR41]; Rampazzo et al. [@CR45]).

In contrast to the above-mentioned genetic strategies, the pharmacological approach relies on testing the SPR fish with drugs that enhance or abrogate the activity of cytoplasmic proteins or more downstream nuclear TFs involved in the physiological responsiveness of the reporter transgene to endogenous ligands. For instance, the DAPT drug is known to block Notch signaling by inhibiting gamma secretase-dependent release of the intracellular domain of Notch receptor (Dovey et al. [@CR13]). As shown in Fig. [2](#Fig2){ref-type="fig"}, treatment of Notch reporter fish with this compound leads to a decrease of Notch responsive activity, as demonstrated by the reduced amount of both reporter messengers and corresponding proteins. Table [1](#Tab1){ref-type="table"} provides a list of signaling pathways and related SPR transgenic lines produced so far, together with various drugs (pathway-specific activators or inhibitors) that have been used to validate each reporter line.Table 1Summary of the signaling pathway zebrafish reporter lines so far generatedSignaling pathwayReporter transgeneDrugEffectReferencesCanonical WntTol2-(7xTCF.Xla siamois:EGFP)LithiumActivationMoro et al. ([@CR41])AlsterpaulloneActivationMoro et al. ([@CR41]BIOActivationValdivia et al. ([@CR58])Tol2-(7xTCF.Xla siamois:EGFP)IWRInhibitionMoro et al. ([@CR41]), Dodge et al. ([@CR11])Tol2(7xTCF.Xla siamois: EGFP/nlsmCherry)XAV939InhibitionMoro, Tiso, Argenton, unpublishedBMPTol2 (2xBRE-AAVmlp:eGFP/d2GFP) Tol2 (2xBRE-AAVmlp-carpb-actin:eGFP)DorsomorphinInhibitionCollery and Link ([@CR6]), Laux et al. ([@CR30])Tol2(2xBRE-AAVmlp:eGFP/nlsmcherry)LDN193189InhibitionMoro, Tiso, Argenton, unpublishedTGFbetaTol2 (12xCAGA:AAVMLP:eGFP/nlsmCherry)SB 431542InhibitionCasari et al., unpublishedFGFpSce1 DUSP6:d2EGFPBCIActivationMolina et al. ([@CR40])SU 5402InhibitionMolina et al. ([@CR39])ShhTol2 (8xGli-cry:mcherry) Tol2 (12xGli.HSV:nlsmCherry)CyclopamineInhibitionSchwend et al. ([@CR49]) Moro, Tiso, Argenton, unpublishedTol2 (12xGli.HSV:nlsmCherry)PurmorphamineActivationWilkinson et al. ([@CR63])NotchTol2 (12xNREbglob:eGFP) Tol2 (6xNREbglob:eGFP)DAPTInhibitionParsons et al. ([@CR43]) Porazzi, Moro, Tiso, Argenton, unpublishedSchematic summary of the recently generated signaling pathway reporter lines and their in vivo characterization through chemical agonists and antagonists. Details about the dosage of each compound are reported in the related reference.

As mentioned before, these drug treatments are intended to be complementary and not exclusive methods for SPR validation. The combined use of all of the above-described strategies has indeed been shown to be the most reliable approach so far adopted to confirm, or exclude, the strength of a given SPR as a genuine reporter for a specific signaling pathway.

SPR lines: limits and applications {#Sec8}
----------------------------------

Zebrafish SPR lines are undoubtedly an invaluable resource for answering many unsolved biological questions regarding tissue communications and cell dynamics occurring in living vertebrates. Their application, however, also implies the knowledge of some possible limitations. First, these may include the incomplete recapitulation of a known signaling cascade in the corresponding SPR line, for instance in terms of number/type of anatomical districts expected to respond, at a given stage or condition, to the specific pathway. These discrepancies may be due to either expected or hard-to-predict genetic, epigenetic or non-genomic events, as well as to mere technical reasons. Some of these situations are clearly exemplified by the FGF reporter line (Molina et al. [@CR39]). In these transgenic embryos, the expression domains of the reporter d2EGFP have not fully recapitulated all the anatomical regions (such as somites and tail bud) where a known FGF target, the gene *dusp6,* is normally activated. The authors discuss this observation, hypothesizing that the 10 Kb *dusp6* promoter region, used to drive the transgene, might lack somitic and tail bud enhancers required for a complete reporter activation. In the same FGF reporter line, another discrepancy has been noted in the wider expression domain of the reporter messenger compared to the encoded d2EGFP. The authors argue that this difference might depend on the threshold level required to visualize the destabilized fluorescent protein, compared to WISH detection of reporter transcripts. Notably, the opposite may also occur, when stable fluorescent reporters display wider and more persistent expression compared to their messengers, which are usually more dynamically regulated (see, for instance, the Notch reporter behavior displayed in Fig. [2](#Fig2){ref-type="fig"}). When concerning another well-established reporter, the Hh-responsive line, Schwend et al. ([@CR49]) acknowledge that despite being the Hh-target *gli1* domains plainly recapitulated by the reporter expression, some Hh-responding regions might not be represented, possibly due to local chromatin effects or other epigenetic factors. In this perspective, the examination of further reporter lines is proposed as a valid strategy to rule out this possibility.

In summary, several factors, including technical limitations in detecting reporter expression, choice of specific responsive elements or partial promoter regions, species-specific or stage-dependent responses, and non-canonical, non-genomic or epigenetic events, may all be taken into account when evaluating the activity of a given SPR transgenic line.

With all these issues in mind, the application of SPR lines to current research has met a large variety of needs so far, ranging from in vivo imaging of developmental and cellular dynamics to adult physiology and regeneration, tumor biology and pharmacological screening. The most obvious application of the existing zebrafish reporter lines is represented by the in vivo analysis of physiological pathway activation throughout the main steps of vertebrate embryonic development (Dorsky et al. [@CR12]; Molina et al. [@CR39]; Schwend et al. [@CR49]; Gorelick and Halpern [@CR17]; Moro et al. [@CR41]). The peculiar optical clarity of zebrafish allows performing this task far beyond gastrulation, somitogenesis or late embryonic stages, reaching also larval or juvenile stages, especially when focusing on more superficial tissues, or exploiting unpigmented fish lines. Reporter analysis in adult individuals is also possible, even if generally focused on external structures or performed by *postmortem* organ dissection, followed by fluorescence microscopy and/or immunohistochemistry. A perfect example of reporter application in living adult fish is described in Moro et al. ([@CR41]), where amputated tail fins of 1-year old transgenic Tg(7xTCF-Xla.Siam:nlsmCherry)ia5 fish are analyzed for Wnt/beta-catenin signaling activation during their epimorphic regeneration process.

Strictly connected with every SPR production is its validation, which, as described before, implies the use of genetic tools, to challenge the reporter behavior, as well as the test of compounds with agonistic/antagonistic effects on the pathway under investigation. Incidentally, these experiments have the additional advantage of validating SPR lines as suitable tools to spot, for instance, biologically significant differences among mutant alleles, or to set up large-scale screens for novel pathway-specific drugs, especially with potential therapeutic relevance. The use of zebrafish SPR lines for in vivo drug screening and validation, in particular, is expected to speed up and improve the whole methodological process, mainly based on the in vitro reporter systems, and commonly validated on model organisms by ex vivo or postmortem histological analyses (Chen et al. [@CR5]). A recent example of such SPR utilization is represented by the GRIZLY assay, a chemical screening system based on glucocorticoid responsive zebrafish, which displays promising applications in stress research, environmental monitoring and drug discovery (Weger et al. [@CR61]). Moreover, with novel SPR lines constantly becoming available, intercross between different transgenic reporters is nowadays feasible, allowing simultaneous analysis of multiple pathways at specific locations, conditions and time points (see, for instance Fig. [3](#Fig3){ref-type="fig"}a, b) and such applications are expected to improve our knowledge on interactions and hierarchical relationships (epistasis) among different signaling cascades activated during vertebrate development or key pathophysiological processes.Fig. 3Examples of applications of zebrafish SPR lines. **a**, **b** Analysis of cephalic Wnt-reporter cells (*red*) in a tissue-specific transgenic background (in **a** vascular-specific *kdrl*:EGFP) or in combination with a Bmp-responsive system (in **b** Bmp:EGFP). *White arrowheads* (in **b**) indicate few cells co-expressing both Wnt- and Bmp-responsive fluorescent proteins. **c** Glioblastoma-derived (GBM) human cells, labeled with EGFP, are xeno-transplanted in the brain of a 1-week old Wnt-responsive zebrafish larva (*0 dpt* 0 days post-transplantation). Reporter expression (*red*) aids in locating transplanted cells close to the Wnt-responsive midbrain--hindbrain boundary (mhb). **d** In this microenvironment, at 1 dpt, a fraction of initially rounded GBM cells start to exhibit cellular projections (*white arrows*). **e** Ductal expression of the Notch reporter (*red*) in the pancreas (labeled in *green* by *ptf1a*:EGFP) of a control 1 month old (1 mpf) larva. **f** Disorganized appearance of the pancreatic tissue (*green*) in a 1 mpf larva expressing the oncogenic chimera Kras-EGFP. Notch-responsive ductal cells (*red*) appear completely dispersed. All figures are confocal Z-stack projections, in lateral view, anterior to the left, acquired with a Nikon C2 confocal microscope

With regard to SPR line application on disease modeling, it is worth mentioning some ongoing tumor studies carried out also by our group with various approaches, involving xeno-transplantation of human cancer cells into zebrafish larvae, and production of genetically engineered onco-fish lines. With these strategies, we aim to identify which signaling microenvironments can promote tumor growth, and which ones are instead able to re-program cancer cells into less aggressive phenotypes. To this end, we have exploited our SPR lines as hosting niches where human cancer cells could be grafted, targeting specific signaling-responsive anatomical regions (Fig. [3](#Fig3){ref-type="fig"}c). Xeno-transplanted cells could be monitored in vivo for several days, embedded in specific pathway-responsive backgrounds, and their phenotype morphologically examined (Fig. [3](#Fig3){ref-type="fig"}d) before proceeding with deeper molecular characterization and cell signaling analysis (Rampazzo et al. [@CR45]). In parallel, our group has produced a number of zebrafish lines expressing the oncogene Kras in CNS and pancreas, to elicit endogenous medulloblastoma- and pancreatic adenocarcinoma-like tumor masses (Schiavone M and Rampazzo E, in preparation). These onco-fish have been crossed with different SPR lines to observe tumor behavior (onset, proliferation, metastasis, regression) in relation to each considered signaling cascade (Fig. [3](#Fig3){ref-type="fig"}e, f). With similar objectives, Santhakumar et al. ([@CR48]) have recently developed a zebrafish Hif (hypoxia inducible factor) signaling reporter, to analyze in vivo the hypoxia response in tumor-prone animals. To build up such reporter system, a Hif-responsive transgene, made by prolyl hydroxylase 3 (*phd3*) promoter/regulatory elements driving EGFP, was analyzed in *vhl* (Von Hippel-Lindau tumor suppressor) mutant zebrafish lines exposed to the carcinogen dimethylbenzanthracene (DMBA). Interestingly, DMBA-treated *vhl* fish showed a high incidence of hepatic and intestinal tumors, in a subset of which strong hypoxia-dependent *phd3:EGFP* expression could be noninvasively detected and characterized.

Taken together, these studies may thus represent a unique opportunity to dissect in real time in a vertebrate model the main steps of tumorigenesis while simultaneously inspecting a series of key signaling pathways activated at the whole-organism level.

SPR lines: further developments and conclusions {#Sec9}
-----------------------------------------------

The generation of zebrafish SPR lines is just beginning, and several signaling pathways are still not represented by corresponding biosensors. These include, for instance, several hormone-dependent pathways, broad-spectrum cascades such as cAMP signaling, Jun/Fos/AP1, or recently characterized pathways, such as Hippo signaling. For the already available SPR lines, taking advantage of a plethora of available molecular tools, including destabilized (e.g. dEGFP), modifiable (e.g. Kaede, Dendra2) or phototoxic/cytotoxic (e.g. Killer Red, Nitroreductase) reporter proteins (Li et al. [@CR31]; Ando et al. [@CR2]; Gurskaya et al. [@CR18]; Dempsey et al. [@CR10]; Korzh et al. [@CR28]; Curado et al. [@CR8]) we can envisage a series of implementations aimed at improving biosensor performances in terms of a more dynamic response as well as the possibilities of cell lineage tracing or ablation. Moreover, spatial and temporal controls can be introduced in a given reporter system, exploiting, for instance, GAL4/UAS-coupled inducible expression, as already shown for the Notch reporter (Parsons et al. [@CR43]). These systems can be further modulated by conditional and irreversible modifications, such as Cre/Lox recombination upon drug exposure (e.g. tamoxifen-regulated CreER), to drive the reporter in specific tissues or cell types, or regulated by temporary treatments, including heat-shock (e.g. Hsp70 promoter) (Stoick-Cooper et al. [@CR54]; Hans et al. [@CR20]). For more advanced SPR imaging technologies, further improvements are expected to arise in parallel with the set-up of large-scale automated small molecule screens, as well as through the combination of imaging and system biology, as recently demonstrated by the authors of Vibe-Z, software developed to map expression data in 3D zebrafish brain atlases (Ronneberger et al. [@CR46]). In this perspective, Walker et al. ([@CR59]) recently described an interesting ad hoc system for Automated Reporter Quantification in vivo (ARQiv), based on a microplate reader designed to detect changes in fluorescent reporters expressed in living zebrafish from embryonic to larval and juvenile stages. This versatile platform, designed to quantify reporter signals at a high-throughput scale at different time points, should be able, for instance, to monitor disease progression or drug action kinetics.

In conclusion, we picture a rapid spread of zebrafish-based SPRs among the scientific community, especially in view of the fact that these biosensors fully meet the 4R principle of experimental animal use (Banks [@CR3]). Undeniably, zebrafish SPRs allow replacement of amniote models with more economical anamniote organisms; moreover, zebrafish SPRs can be refined toward early life stages (embryos, larvae and juveniles). Finally, zebrafish SPRs significantly reduce the number of experimental animals by means of repeatable live imaging, in this way fully exploiting the extraordinary properties of manipulability and optical accessibility of this vertebrate model, without affecting a responsible use of animals in research protocol.
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